River Global Investors LLP Trims Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

River Global Investors LLP trimmed its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 5.6% in the 4th quarter, HoldingsChannel reports. The fund owned 48,857 shares of the company’s stock after selling 2,921 shares during the quarter. River Global Investors LLP’s holdings in Bath & Body Works were worth $2,108,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Federated Hermes Inc. lifted its stake in shares of Bath & Body Works by 17.1% in the 4th quarter. Federated Hermes Inc. now owns 1,612 shares of the company’s stock valued at $70,000 after purchasing an additional 235 shares during the last quarter. Commonwealth Equity Services LLC lifted its position in Bath & Body Works by 3.3% in the third quarter. Commonwealth Equity Services LLC now owns 11,044 shares of the company’s stock valued at $373,000 after buying an additional 348 shares during the last quarter. CWM LLC boosted its stake in Bath & Body Works by 7.3% during the fourth quarter. CWM LLC now owns 5,167 shares of the company’s stock worth $223,000 after buying an additional 353 shares during the period. DekaBank Deutsche Girozentrale increased its position in shares of Bath & Body Works by 1.3% during the fourth quarter. DekaBank Deutsche Girozentrale now owns 31,475 shares of the company’s stock valued at $1,349,000 after acquiring an additional 414 shares during the last quarter. Finally, Diversified Trust Co increased its position in shares of Bath & Body Works by 1.9% during the fourth quarter. Diversified Trust Co now owns 23,663 shares of the company’s stock valued at $1,021,000 after acquiring an additional 435 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Insider Transactions at Bath & Body Works

In related news, insider Thomas E. Mazurek sold 4,285 shares of the company’s stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the transaction, the insider now directly owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.19% of the company’s stock.

Bath & Body Works Stock Up 4.9 %

NYSE BBWI traded up $2.14 on Friday, hitting $45.97. 2,585,013 shares of the stock were exchanged, compared to its average volume of 2,601,801. Bath & Body Works, Inc. has a fifty-two week low of $27.30 and a fifty-two week high of $50.34. The company has a 50-day moving average price of $46.07 and a 200-day moving average price of $41.03. The company has a market cap of $10.34 billion, a PE ratio of 11.94, a PEG ratio of 1.42 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.21. The firm had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company’s revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.86 earnings per share. As a group, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were issued a $0.20 dividend. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.74%. Bath & Body Works’s payout ratio is currently 20.78%.

Wall Street Analyst Weigh In

BBWI has been the subject of a number of research analyst reports. Wells Fargo & Company increased their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 24th. Evercore ISI lifted their price objective on Bath & Body Works from $30.00 to $45.00 and gave the company an “in-line” rating in a research note on Friday, March 1st. Telsey Advisory Group reissued an “outperform” rating and set a $53.00 target price on shares of Bath & Body Works in a research note on Friday, April 5th. BMO Capital Markets raised their target price on Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Finally, UBS Group boosted their price target on shares of Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a research note on Monday, March 4th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $46.73.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.